日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

DART/SWOG/NCI phase II anti-CTLA-4/PD-1 trial: clear cell carcinomas of ovary, endometrium, cervix

DART/SWOG/NCI II期抗CTLA-4/PD-1试验:卵巢、子宫内膜、宫颈透明细胞癌

Chae, Young Kwang; Othus, Megan; Patel, Sandip P; Backes, Floortje J; O'Malley, David M; Cristea, Mihaela; Naing, Aung; Kurnit, Katherine; Eskander, Ramez N; T Goodrich, Scott; Robinson, William R; Scalici, Jennifer; Chan, John; Ali-Ahmad, Hussein; Hays, John; McCormick, Colleen; Kim, Edward J; Sueblinvong, Thanasak; Ahmed, Amina; Siedel, Jean; Thomes Pepin, Jessica; Bottsford-Miller, Justin Neal; Fagbemi, Seth Olusegun; Jaslowski, Anthony John; Kim, Hye Sung; Chung, Liam Il-Young; Moloney-Lineen, Carolyn; McLeod, Christine M; Chen, Helen X; Sharon, Elad; Streicher, Howard; Ryan, Christopher W; Blanke, Charles D; Kurzrock, Razelle

A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis

一项针对复发/难治性B细胞淋巴瘤的blinatumomab/来那度胺I期研究:毒性、疗效及相关性分析

Tuscano, Joseph M; Othman, Tamer; Frankel, Paul; Ruel, Christopher; Poh, Christina; Herbert, Samantha; Maverakis, Emanual; Merleev, Alexander A; Luxardi, Guillaume; Abedi, Mehrdad; Ranganathan, Raghuveer; Modi, Dipenkumar; Zain, Jasmine; Budde, Elizabeth L; Mei, Matthew; Rosenberg, Aaron S; Hoeg, Rasmus T; Costello, Caitlin; Foss, Francine M; William, Basem M; Holland, H Kent; Sharon, Elad; Streicher, Howard; Danilov, Alexy; Newman, Edward

Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma

辅助性帕博利珠单抗治疗与观察治疗肌层浸润性尿路上皮癌的比较

Apolo, Andrea B; Ballman, Karla V; Sonpavde, Guru; Berg, Stephanie; Kim, William Y; Parikh, Rahul; Teo, Min Yuen; Sweis, Randy F; Geynisman, Daniel M; Grivas, Petros; Chatta, Gurkamal; Reichert, Zachery Roger; Kim, Joseph W; Bilen, Mehmet Asim; McGregor, Bradley; Singh, Parminder; Tripathi, Abhishek; Cole, Suzanne; Simon, Nicholas; Niglio, Scot; Ley, Lisa; Cordes, Lisa; Srinivas, Sandy; Huang, Jiaoti; Odegaard, Meagan; Watt, Colleen; Petrylak, Daniel; Hoffman-Censits, Jeannie; Wen, Yujia; Hahn, Olwen; Mitchell, Cecilia; Tan, Alan; Streicher, Howard; Sharon, Elad; Moon, Helen; Woods, Michael; Halabi, Susan; Perez Burbano, Gabriela; Morris, Michael J; Rosenberg, Jonathan E

A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: durable responses and delayed pseudoprogression in small cell carcinoma of the ovary, hypercalcemic type cohort

一项针对罕见肿瘤的双重抗CTLA-4和抗PD-1阻断疗法的II期篮式试验(DART)SWOG S1609:卵巢小细胞癌高钙血症型队列的持久缓解和延迟假性进展

Chae, Young Kwang; Othus, Megan; Patel, Sandip Pravin; Aljumaily, Raid; Win, Khine Z; Pejovic, Tanya; Thomas, Sajeve S; Robinson, William R 3rd; Kim, Hye Sung; Chung, Liam Il-Young; McLeod, Christine M; Chen, Helen X; Sharon, Elad; Streicher, Howard; Ryan, Christopher W; Blanke, Charles D; Kurzrock, Razelle

Immunological biomarkers of response and resistance to treatment with cabozantinib and nivolumab in recurrent endometrial cancer

复发性子宫内膜癌对卡博替尼和纳武利尤单抗治疗的反应和耐药性的免疫学生物标志物

Roudko, Vladimir; Del Valle, Diane Marie; Radkevich, Emir; Kelly, Geoffrey; Hui, Xie; Patel, Manishkumar; Gonzalez-Kozlova, Edgar; Tuballes, Kevin; Streicher, Howard; Atale, Swati; Wang, Lisa; CzinCzin, Benito; Kim-Schulze, Seunghee; Wistuba, Ignacio I; Haymaker, Cara L; Al-Atrash, Gheath; Manyam, Ganiraju; Zhang, Jianjun; Thompson, Ryan; Suarez-Farinas, Mayte; Lheureux, Stephanie; Gnjatic, Sacha

Phase 1 study evaluating the safety, preliminary efficacy, and pharmacodynamics of recombinant interleukin-15 in combination with nivolumab and ipilimumab in patients with refractory cancers

一项评估重组白细胞介素-15联合纳武利尤单抗和伊匹木单抗治疗难治性癌症患者的安全性、初步疗效和药效学的I期研究

Ahmed, Jibran; O'Sullivan Coyne, Geraldine; Rubinstein, Larry V; Shin, Sarah J; Takebe, Naoko; Bruns, Ashley; Augustine, Brooke; Mukherjee, Jessica; Ma, Ning; Fino, Kristin; Fung, King Leung; Ferry-Galow, Katherine V; Johnson, Barry C; Parchment, Ralph E; Streicher, Howard; Doroshow, James H; Chen, Alice P

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors SWOG S1609: Vulvar Cancers

一项针对罕见肿瘤的双重抗CTLA-4和抗PD-1阻断疗法的II期篮式试验 SWOG S1609:外阴癌

Chae, Young Kwang; Corthell, Lucy; Patel, Sandip Pravin; Edwards, Robert; Scalici, Jennifer M; Kim, Hye Sung; Chung, Liam Il-Young; Othus, Megan; McLeod, Christine M; Chen, Helen X; Sharon, Elad; Streicher, Howard; Ryan, Christopher W; Blanke, Charles D; Kurzrock, Razelle

Integrative Immune Signature of Complementary Circulating and Tumoral Biomarkers Maximizes the Predictive Power of Adjuvant Immunotherapeutic Benefits in High-risk Melanoma

整合循环和肿瘤互补生物标志物的免疫特征可最大限度地提高高危黑色素瘤辅助免疫治疗获益的预测能力

Tarhini, Ahmad A; Obermayer, Alyssa; Lee, Sandra J; LaFramboise, William A; Hodi, F Stephen; Karunamurthy, Arivarasan D; Eljilany, Islam; Chen, Dung-Tsa; Hwu, Patrick; El Naqa, Issam M; Streicher, Howard; Sondak, Vernon K; Storkus, Walter J; Butterfield, Lisa H; Shaw, Timothy I; Kirkwood, John M

First cycle toxicity and survival in patients with rare cancers treated with checkpoint inhibitors

接受免疫检查点抑制剂治疗的罕见癌症患者的首疗程毒性和生存率

Othus, Megan; Patel, Sandip P; Chae, Young Kwang; Dietrich, Eliana; Streicher, Howard; Sharon, Elad; Kurzrock, Razelle

Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemia

一项随机 II 期研究旨在评估单药纳武利尤单抗在维持急性髓系白血病缓解中的作用。

Pyzer, Athalia R; Dillon, Laura W; Sharon, Elad; Karrison, Theodore G; Zha, Yuanyuan; Fulton, Noreen; Gui, Gege; Andrew, Georgia; Streicher, Howard; Sweet, Kendra; Yaghmour, George; Liu, Jane Jijun; Jonas, Brian A; Schimmer, Aaron D; Grant, Steven; Zeidan, Amer M; Hildebrandt, Gerhard C; Lowrey, Christopher H; Mattison, Ryan J; Palmisiano, Neil; Salhotra, Amandeep; Tzachanis, Dimitrios; Baer, Maria R; Lin, Tara L; Patel, Prapti; Chen, Helen; Stadler, Walter M; Odenike, Olatoyosi; Larson, Richard A; Gajewski, Thomas F; Hourigan, Christopher S; Stock, Wendy; Liu, Hongtao